Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

[Health-economic burden of Parkinson's disease in Portugal: a cohort study].

Reese JP, Winter Y, Rosa MM, Rodrigues E Silva AM, von Campenhausen S, Freire R, Mateus C, Balzer-Geldsetzer M, Botzel K, Oertel WH, Dodel R, Sampaio C.

Rev Neurol. 2011 Mar 1;52(5):264-74. Spanish.

PMID:
21341221
[PubMed - indexed for MEDLINE]
Free Article
2.

Economic burden of Parkinson's disease in Singapore.

Zhao YJ, Tan LC, Li SC, Au WL, Seah SH, Lau PN, Luo N, Wee HL.

Eur J Neurol. 2011 Mar;18(3):519-26. doi: 10.1111/j.1468-1331.2010.03210.x. Epub 2010 Sep 14.

PMID:
20840378
[PubMed - indexed for MEDLINE]
3.

[Parkinson's disease: cost-of-illness in an outpatient cohort].

Reese JP, Winter Y, Balzer-Geldsetzer M, Bötzel K, Eggert K, Oertel WH, Dodel R, Campenhausen Sv.

Gesundheitswesen. 2011 Jan;73(1):22-9. doi: 10.1055/s-0030-1247571. Epub 2010 Mar 12. German.

PMID:
20229454
[PubMed - indexed for MEDLINE]
4.

Costs of illness in a Russian cohort of patients with Parkinson's disease.

Winter Y, von Campenhausen S, Popov G, Reese JP, Klotsche J, Bötzel K, Gusev E, Oertel WH, Dodel R, Guekht A.

Pharmacoeconomics. 2009;27(7):571-84. doi: 10.2165/11310160-000000000-00000.

PMID:
19663528
[PubMed - indexed for MEDLINE]
5.

Longitudinal study of the socioeconomic burden of Parkinson's disease in Germany.

Winter Y, Balzer-Geldsetzer M, Spottke A, Reese JP, Baum E, Klotsche J, Rieke J, Simonow A, Eggert K, Oertel WH, Dodel R.

Eur J Neurol. 2010 Sep;17(9):1156-63. doi: 10.1111/j.1468-1331.2010.02984.x. Epub 2010 Mar 22.

PMID:
20345926
[PubMed - indexed for MEDLINE]
6.

A review of the health-related quality of life and economic impact of Parkinson's disease.

Dowding CH, Shenton CL, Salek SS.

Drugs Aging. 2006;23(9):693-721. Review.

PMID:
17020395
[PubMed - indexed for MEDLINE]
7.

Costs of Parkinson's disease in eastern Europe: a Czech cohort study.

Winter Y, von Campenhausen S, Brozova H, Skoupa J, Reese JP, Bötzel K, Eggert K, Oertel WH, Dodel R, Ruzicka E.

Parkinsonism Relat Disord. 2010 Jan;16(1):51-6. doi: 10.1016/j.parkreldis.2009.07.005. Epub 2009 Aug 8.

PMID:
19665915
[PubMed - indexed for MEDLINE]
8.

[Impact of motor and non-motor symptoms on the direct costs of Parkinson's disease].

Cubo E, Martínez Martin P, González M, Frades B; miembros del grupo ELEP.

Neurologia. 2009 Jan-Feb;24(1):15-23. Spanish.

PMID:
19003550
[PubMed - indexed for MEDLINE]
9.

The economic burden of advanced Parkinson’s disease: an analysis of a UK patient dataset.

Findley LJ, Wood E, Lowin J, Roeder C, Bergman A, Schifflers M.

J Med Econ. 2011;14(1):130-9. doi: 10.3111/13696998.2010.551164.

PMID:
21235405
[PubMed - indexed for MEDLINE]
10.

Economic burden associated with Parkinson's disease on elderly Medicare beneficiaries.

Noyes K, Liu H, Li Y, Holloway R, Dick AW.

Mov Disord. 2006 Mar;21(3):362-72.

PMID:
16211621
[PubMed - indexed for MEDLINE]
11.

Economic burden of Parkinson's disease in a developing country: a retrospective cost analysis in Shanghai, China.

Wang G, Cheng Q, Zheng R, Tan YY, Sun XK, Zhou HY, Ye XL, Wang Y, Wang Z, Sun BM, Chen SD.

Mov Disord. 2006 Sep;21(9):1439-43.

PMID:
16773620
[PubMed - indexed for MEDLINE]
12.

Burden of illness in Parkinson's disease.

Huse DM, Schulman K, Orsini L, Castelli-Haley J, Kennedy S, Lenhart G.

Mov Disord. 2005 Nov;20(11):1449-54.

PMID:
16007641
[PubMed - indexed for MEDLINE]
13.

Health economic burden of patients with restless legs syndrome in a German ambulatory setting.

Dodel R, Happe S, Peglau I, Mayer G, Wasem J, Reese JP, Giani G, Geraedts M, Trenkwalder C, Oertel WH, Stiasny-Kolster K.

Pharmacoeconomics. 2010;28(5):381-93. doi: 10.2165/11531030-000000000-00000.

PMID:
20297866
[PubMed - indexed for MEDLINE]
14.

The health burdens of Parkinson's disease.

Chrischilles EA, Rubenstein LM, Voelker MD, Wallace RB, Rodnitzky RL.

Mov Disord. 1998 May;13(3):406-13.

PMID:
9613729
[PubMed - indexed for MEDLINE]
15.

Resource use and costs in a Swedish cohort of patients with Parkinson's disease.

Hagell P, Nordling S, Reimer J, Grabowski M, Persson U.

Mov Disord. 2002 Nov;17(6):1213-20.

PMID:
12465059
[PubMed - indexed for MEDLINE]
16.

Costs of illness and care in Parkinson's disease: an evaluation in six countries.

von Campenhausen S, Winter Y, Rodrigues e Silva A, Sampaio C, Ruzicka E, Barone P, Poewe W, Guekht A, Mateus C, Pfeiffer KP, Berger K, Skoupa J, Bötzel K, Geiger-Gritsch S, Siebert U, Balzer-Geldsetzer M, Oertel WH, Dodel R, Reese JP.

Eur Neuropsychopharmacol. 2011 Feb;21(2):180-91. doi: 10.1016/j.euroneuro.2010.08.002.

PMID:
20888737
[PubMed - indexed for MEDLINE]
17.

Quality of life, caregiver burden and insurance in patients with Parkinson's disease in Germany.

Müller T, Woitalla D.

Eur J Neurol. 2010 Nov;17(11):1365-9. doi: 10.1111/j.1468-1331.2010.03033.x.

PMID:
20443985
[PubMed - indexed for MEDLINE]
18.

Cost of illness and its predictors for Parkinson's disease in Germany.

Spottke AE, Reuter M, Machat O, Bornschein B, von Campenhausen S, Berger K, Koehne-Volland R, Rieke J, Simonow A, Brandstaedter D, Siebert U, Oertel WH, Ulm G, Dodel R.

Pharmacoeconomics. 2005;23(8):817-36.

PMID:
16097843
[PubMed - indexed for MEDLINE]
19.

A comparison of health-care costs involved in treating people with and without Parkinson's disease in Southern Sydney, New South Wales, Australia.

Cordato DJ, Schwartz R, Abbott E, Saunders R, Morfis L.

J Clin Neurosci. 2006 Jul;13(6):655-8. Epub 2006 Jun 23.

PMID:
16797991
[PubMed - indexed for MEDLINE]
20.

Economic and health-related quality of life considerations of new therapies in Parkinson's disease.

Rubenstein LM, DeLeo A, Chrischilles EA.

Pharmacoeconomics. 2001;19(7):729-52. Review.

PMID:
11548910
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk